peoniflorin and Hypertension--Pulmonary

peoniflorin has been researched along with Hypertension--Pulmonary* in 1 studies

Other Studies

1 other study(ies) available for peoniflorin and Hypertension--Pulmonary

ArticleYear
Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-κB pathways.
    International journal of medical sciences, 2022, Volume: 19, Issue:4

    Topics: Animals; Disease Models, Animal; Endothelial Cells; Glucosides; Hypertension, Pulmonary; MAP Kinase Kinase Kinases; Monocrotaline; Monoterpenes; NF-kappa B; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats

2022